Inhalable ibuprofen may be the future of cystic fibrosis treatment
Researchers from the Texas A&M Health Science Center College of Medicine (Round Rock, TX, USA) are developing an inhalable form of ibuprofen, which could be used to treat cystic fibrosis patients without the negative side effects associated with high doses of ibuprofen.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.